VidPrevtyn Beta® vaccine effectiveness against COVID-19 hospitalisations in the UK
Not Applicable
- Conditions
- COVID-19Infections and Infestations
- Registration Number
- ISRCTN95900937
- Lead Sponsor
- Sanofi (France)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 617000
Inclusion Criteria
This study will include all individuals aged 18 years or older who are eligible to receive a VidPrevtyn Beta vaccine.
Exclusion Criteria
Individuals <18 years and those who are ineligible to receive a VidPrevtyn Beta vaccine.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method